James E. Bradner - 06 May 2025 Form 4 Insider Report for AMGEN INC (AMGN)

Role: EVP, R&D, & Chief Sci. Officer
Signature: /s/ James E. Bradner
Issuer symbol: AMGN
Transactions as of: 06 May 2025
Net transactions value: +$6,204,975
Form type: 4
Filing time: 08 May 2025, 20:49:53 UTC
Previous filing: 09 May 2024
Next filing: 10 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Bradner James E.	EVP, R&D, & Chief Sci. Officer	ONE AMGEN CENTER DRIVE, THOUSAND OAKS	/s/ James E. Bradner	08 May 2025	0002005159

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMGN	Common Stock	Award	$0	+3,549	+14%	$0.000000	29,753	06 May 2025	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMGN	Nqso (Right to Buy)	Award	$6,204,975	+22,944		$270.44	22,944	06 May 2025	Common Stock	22,944	$270.44	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/6/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2	These shares include 948 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F3	These non-qualified stock options were granted pursuant to the Equity Incentive Plan and are exercisable in four equal annual installments of 25% each commencing on 5/6/2026.